CBD stocks have come under fire after this move by the FDA, but for NRTI it is a REAL POSITIVE! It has now put them far ahead of all those other CBD companies that were jumping on the bandwagon by taking shortcuts to get CBD products in the marketplace. Only problem is that the company has to let us know what is going on and to set up a meeting with the FDA to review their Gold Standard approach to see if the FDA requires additional steps to gain their approval.
We don't need these other PR's that always have a negative effect on the share price. When will they figure out that CBD is the only thing that investors care about here? Cheers!
News 
Market Data 
Discover 
AI
